Profile data is unavailable for this security.
About the company
INOVIQ Ltd is an Australia-based biotechnology company developing diagnostics and therapeutics for cancer. The Company's commercialized products include EXO-NET exosome isolation technology for biomarker discovery and diagnostics development, and the hTERT test as an adjunct test for bladder cancer. The Company is also advancing clinical-stage diagnostics for the detection and monitoring of ovarian and breast cancers, and early-stage exosome therapeutics for solid tumors.
- Revenue in AUD (TTM)959.32k
- Net income in AUD-6.93m
- Incorporated1983
- Employees85.00
- LocationINOVIQ Ltd23 Normanby Road, Notting HillNEDLANDS 3168AustraliaAUS
- Phone+61 39548-7586
- Fax+61 89388-7559
- Websitehttps://www.inoviq.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TrivarX Ltd | 1.13m | -943.23k | 25.38m | 4.00 | -- | 1.08 | -- | 22.41 | -0.0018 | -0.0018 | 0.0023 | 0.0204 | 0.0923 | -- | -- | -- | -7.68 | -33.47 | -8.32 | -37.46 | -- | -- | -83.27 | -373.85 | -- | -27.05 | 0.0132 | -- | 26.38 | 3.89 | 34.25 | -- | 6.29 | -- |
| Avecho Biotechnology Ltd | 1.38m | -3.62m | 36.73m | 29.00 | -- | 38.46 | -- | 26.61 | -0.0011 | -0.0011 | 0.0004 | 0.0003 | 0.2115 | 4.46 | 1.91 | -- | -55.49 | -61.23 | -72.92 | -73.27 | 62.27 | 55.45 | -262.41 | -382.04 | 4.53 | -8.03 | 0.0647 | -- | 139.19 | -23.20 | 9.15 | -- | -- | -- |
| Vitura Health Ltd | 124.04m | 3.28m | 37.11m | 119.00 | 10.37 | 0.7694 | 7.00 | 0.2992 | 0.0054 | 0.0054 | 0.2034 | 0.0728 | 1.69 | 16.43 | 10.46 | -- | 4.11 | 12.75 | 5.72 | 17.62 | 27.21 | 30.97 | 2.43 | 6.06 | 1.05 | 9.50 | 0.2009 | -- | 0.1341 | 298.23 | -5.35 | -- | 129.38 | -- |
| Little Green Pharma Ltd | 38.49m | 5.86m | 38.21m | -- | 6.46 | 0.4442 | 3.94 | 0.9925 | 0.0194 | 0.0194 | 0.1268 | 0.2814 | 0.4262 | 0.8199 | 14.01 | -- | 6.48 | -- | 7.09 | -- | 67.46 | -- | 15.21 | -- | 0.8728 | -4.71 | 0.0541 | -- | 43.67 | -- | 140.77 | -- | -- | -- |
| Next Science Ltd | 31.46m | -13.44m | 42.43m | -- | -- | -- | -- | 1.35 | -0.046 | -0.046 | 0.1077 | -0.0027 | 2.07 | 5.42 | 5.69 | -- | -88.62 | -72.67 | -148.75 | -86.87 | 82.48 | 77.69 | -42.74 | -87.99 | 1.25 | -13.18 | 1.12 | -- | 2.87 | 41.23 | 34.94 | -- | -18.19 | -- |
| Inoviq Ltd | 959.32k | -6.93m | 46.46m | 85.00 | -- | 2.20 | -- | 48.43 | -0.0623 | -0.0623 | 0.0086 | 0.1497 | 0.0478 | 3.73 | 0.6725 | -- | -34.52 | -43.01 | -37.36 | -45.87 | 87.45 | 89.08 | -722.62 | -1,543.44 | 5.72 | -- | 0.022 | -- | 21.17 | 57.69 | -5.77 | -- | -- | -- |
| Medical Developments International Ltd | 39.06m | 94.00k | 53.51m | 68.00 | 565.48 | 0.9711 | 16.23 | 1.37 | 0.0008 | 0.0008 | 0.3469 | 0.4891 | 0.6221 | 1.06 | 5.31 | -- | 0.1497 | -16.68 | 0.1738 | -18.92 | 75.35 | 72.70 | 0.2407 | -47.08 | 3.33 | -- | 0.0349 | -- | 17.82 | 11.30 | 100.23 | -24.33 | -34.91 | -- |
| Neurizon Therapeutics Ltd | 1.88m | -16.59m | 68.86m | 52.00 | -- | 17.75 | -- | 36.59 | -0.0334 | -0.0334 | 0.0038 | 0.0056 | 0.2431 | -- | 203.57 | -- | -214.34 | -65.69 | -254.22 | -74.86 | -- | -- | -881.68 | -368.00 | -- | -- | 0.00 | -- | -- | -- | -86.45 | -- | -44.79 | -- |
Data as of Feb 10 2026. Currency figures normalised to INOVIQ Ltd's reporting currency: Australian Dollar AUD
8.76%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Merchant Funds Management Pty Ltd.as of 13 Sep 2024 | 11.67m | 8.29% |
| Netwealth Investments Ltd.as of 01 Sep 2025 | 670.39k | 0.48% |
Data from 09 Dec 2024 - 02 Feb 2026Source: FactSet Research Systems Inc.
